↓ Skip to main content

Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, February 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#23 of 924)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
8 news outlets
blogs
3 blogs
policy
1 policy source
twitter
7 X users
patent
14 patents
googleplus
1 Google+ user

Readers on

mendeley
94 Mendeley